Nucleic Acid Testing - Global Strategic Business Report

The global market for Nucleic Acid Testing is estimated at US$3.2 Billion in 2023 and is projected to reach US$4.4 Billion by 2030, growing at a CAGR of 4.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

The increasing application of NAT in genetic testing, forensic science, and the support of regulatory bodies and governments further boost market growth. NAT`s ability to detect and quantify minute amounts of genetic material makes it invaluable in genetic research and diagnostics, as well as in forensic applications for identifying individuals in criminal investigations and disaster victim identification. As technology continues to evolve, the demand for precise and rapid diagnostics is expected to drive substantial growth in the NAT market, affirming its integral role in healthcare and scientific advancements.

Key Insights:

• Market Growth: Understand the significant growth trajectory of the Nucleic Acid Test Kits segment, which is expected to reach US$3.7 Billion by 2030 with a CAGR of a 5.1%. The Nucleic Acid Testing Consumables segment is also set to grow at 1.8% CAGR over the analysis period.
• Regional Analysis: Gain insights into the U.S. market, estimated at $871.8 Million in 2023, and China, forecasted to grow at an impressive 7.8% CAGR to reach $950.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

• Detailed Market Analysis: Access a thorough analysis of the Global Nucleic Acid Testing Market, covering all major geographic regions and market segments.
• Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
• Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Nucleic Acid Testing Market.
• Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

• How is the Global Nucleic Acid Testing Market expected to evolve by 2030?
• What are the main drivers and restraints affecting the market?
• Which market segments will grow the most over the forecast period?
• How will market shares for different regions and segments change by 2030?
• Who are the leading players in the market, and what are their prospects?

Report Features:

• Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
• In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
• Company Profiles: Coverage of major players such as Abbott Molecular, Inc., Beckman Coulter - Life Science Division, Becton, Dickinson and Company, and more.
• Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Select Competitors (Total 46 Featured):

• Abbott Molecular, Inc.
• Beckman Coulter - Life Science Division
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche AG
• Illumina, Inc.
• Novartis International AG
• Sequenom, Inc.
• Siemens Healthineers
• Tecan Group Ltd.